Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- MHRA guidance on Coronavirus (COVID-19)
- Drug and device alerts
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Blood regulation and safety
- Marketing authorisations and licensing guidance
- Patient information leaflets and summaries of product characteristics
- Public assessment reports
- Medical devices regulation and safety
- Contact MHRA
- All MHRA services and information
Featured
Collection
MHRA guidance on coronavirus (COVID-19)
We are producing guidance and information for industry, healthcare professionals and patients covering the coronavirus (COVID-19) outbreak.
Press release
Don’t rely on temperature screening products for detection of coronavirus (COVID-19), says MHRA
Warning that thermal cameras and other such “temperature screening” products, some of which make direct claims to screen for COVID-19, are not a reliable way to detect if people have the virus.
Guidance
How tests and testing kits for coronavirus (COVID-19) work
The different types of tests and testing kits for COVID-19, and the specifications for manufacturers.
Press release
MHRA suspends recruitment to COVID-19 hydroxychloroquine trials
The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed UK clinical trialists using hydroxychloroquine to treat or prevent coronavirus (COVID-19) to suspend recruitment of further participants.
Detailed guide
3D printing (additive manufacturing) of medical devices or component parts during the coronavirus (COVID-19) pandemic
The requirements for 3D printed products will depend on whether they are classed as medical devices, personal protective equipment (PPE) or both.
News story
Action taken to halt sales of fingerprick coronavirus (COVID-19) antibody testing kits
Anyone supplying these types of tests should temporarily stop this service.
Latest from the Medicines and Healthcare products Regulatory Agency
What the Medicines and Healthcare products Regulatory Agency does
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Policy papers and consultations
- How should we engage and involve patients and the public in our work
- MHRA consultation on EU exit no-deal legislative proposals
Transparency and freedom of information releases
- Medicines and Healthcare products Regulatory Agency spending over £25,000: 2019 to 2020
- Medicines and Healthcare products Regulatory Agency Senior Officials' expenses from October to December 2018
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Please get in touch with us by phone or email during the coronavirus (COVID-19) response period.
In line with the Government’s advice, our building at 10 South Colonnade closed at 5pm on Friday 27 March.
Office hours are Monday to Friday, 9am to 5pm.
For out of hours emergency calls on COVID-19 and regulatory flexibilities queries please call 020 3080 6725 between 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
Corporate information
Jobs and contracts